Inclusion of extracellular matrix molecules and necrostatin-1 in the intracapsular environment of alginate-based microcapsules synergistically protects pancreatic β cells against cytokine-induced inflammatory stress
Source abstract
Abstract
Immunoisolation of pancreatic islets in alginate-based microcapsules is a promising approach for grafting of islets in absence of immunosuppression. However, loss and damage to the extracellular matrix (ECM) during islet isolation enhance susceptibility of islets for inflammatory stress. In this study, a combined strategy was applied to reduce this stress by incorporating ECM components (collagen type IV/RGD) and necroptosis inhibitor, necrostatin-1 (Nec-1) in alginate-based microcapsules in vitro. To demonstrate efficacy, viability and function of MIN6 β-cells and human islets in capsules with collagen type IV/RGD and/or Nec-1 was investigated in presence and absence of IL-1β, IFN-γ and TNF-α. The combination of collagen type IV/RGD and Nec-1 had higher protective effects than the molecules alone. Presence of collagen type IV/RGD and Nec-1 in the intracapsular environment reduced cytokine-induced overproduction of free radical species and unfavorable shifts in mitochondrial dynamics. In addition, the ECM components collagen type IV/RGD prevented a cytokine induced suppression of the FAK/Akt pathway. Our data indicate that the inclusion of collagen type IV/RGD and Nec-1 in the intracapsular environment prevents islet-cell loss when exposed to inflammatory stress, which might contribute to higher survival of β-cells in the immediate period after transplantation. This approach of inclusion of stress reducing agents in the intracapsular environment of immunoisolating devices may be an effective way to enhance the longevity of encapsulated islet grafts. STATEMENT OF SIGNIFICANCE: Islet-cells in immunoisolated alginate-based microcapsules are very susceptible to inflammatory stress which impacts long-term survival of islet grafts. Here we show that incorporation of ECM components (collagen type IV/RGD) and necrostatin-1 (Nec-1) in the intracapsular environment of alginate-based capsules attenuates this susceptibility and promotes islet-cell survival. This effect induced by collagen type IV/RGD and Nec-1 was probably due to lowering free radical production, preventing mitochondrial dysfunction and by maintaining ECM/integrin/FAK/Akt signaling and Nec-1/RIP1/RIP3 signaling. Our study provides an effective strategy to extend longevity of islet grafts which might be of great potential for future clinical application of immunoisolated cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Pancreatic function and diabetes · Diabetes and associated disorders · Diabetes Management and Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (72)
Show source-provided references
1. Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges
2. Advances in β-cell replacement therapy for the treatment of type 1 diabetes10.1016/S0140-6736(19)31334-0 ↗
3. International trial of the edmonton protocol for islet transplantation10.1056/NEJMoa061267 ↗
4. International trial of the Edmonton protocol for islet transplantation10.1056/NEJMoa061267 ↗
5. Current perspective and advancements of alginate-based transplantation technologies alginates-recent uses of this natural polymer
6. Alginate-based microcapsules for immunoisolation of pancreatic islets10.1016/j.biomaterials.2006.07.010 ↗
7. Advances in islet encapsulation technologies10.1038/nrd.2016.232 ↗
8. Treatment of diabetes with encapsulated islets10.1007/978-1-4419-5786-3_5 ↗
9. Tissue responses against immunoisolating alginate-PLL capsules in the immediate posttransplant period10.1002/jbm.10345 ↗
10. Interconnected toroidal hydrogels for islet encapsulation10.1002/adhm.201900423 ↗
11. Toll-like receptor 2-modulating pectin-polymers in alginate-based microcapsules attenuate immune responses and support islet-xenograft survival10.1016/j.biomaterials.2020.120460 ↗
12. Alginate encapsulation as long-term immune protection of allogeneic pancreatic islet cells transplanted into the omental bursa of macaques10.1038/s41551-018-0275-1 ↗
13. Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases10.2337/dc11-0731 ↗
14. Polymeric approaches to reduce tissue responses against devices applied for islet-cell encapsulation10.3389/fbioe.2019.00134 ↗
15. Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets10.1016/S1471-4914(02)02381-X ↗
16. Long-term biocompatibility, chemistry, and function of microencapsulated pancreatic islets10.1016/S0142-9612(02)00319-8 ↗
17. Zwitterionically modified alginates mitigate cellular overgrowth for cell encapsulation10.1038/s41467-019-13238-7 ↗
18. Rebuilding a better home for transplanted islets10.1080/15476278.2018.1517509 ↗
19. Therapeutic strategies for modulating the extracellular matrix to improve pancreatic islet function and survival after transplantation10.1007/s11892-018-1014-4 ↗
20. RGD-containing elastin-like polypeptide improves islet transplantation outcomes in diabetic mice10.1016/j.actbio.2019.06.011 ↗
21. Laminin and collagen IV inclusion in immunoisolating microcapsules reduces cytokine-mediated cell death in human pancreatic islets10.1002/term.2472 ↗
22. Extracellular matrix components supporting human islet function in alginate-based immunoprotective microcapsules for treatment of diabetes10.1002/jbm.a.35706 ↗
23. Collagen IV-modified scaffolds improve islet survival and function and reduce time to euglycemia10.1089/ten.tea.2013.0033 ↗
24. Extracellular matrix molecules and their potential contribution to the function of transplanted pancreatic islets10.1007/s00125-017-4524-8 ↗
25. DAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-110.1038/srep14623 ↗
26. Enzymes for Pancreatic Islet Isolation Impact Chemokine-Production and Polarization of Insulin-Producing β-Cells with Reduced Functional Survival of Immunoisolated Rat Islet-Allografts as a Consequence10.1371/journal.pone.0147992 ↗
27. Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications10.1016/j.phrs.2020.105297 ↗
28. Necrostatin-1 supplementation enhances young porcine islet maturation and in vitro function10.1111/xen.12555 ↗
29. The effects of necrostatin-1 on the in vitro development and function of young porcine islets over 14-day prolonged tissue culture10.1111/xen.12667 ↗
30. Dose-dependent effects of necrostatin-1 supplementation to tissue culture media of young porcine islets10.1371/journal.pone.0243506 ↗
31. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography10.1056/NEJMc070201 ↗
32. Acetate and butyrate improve β-cell metabolism and mitochondrial respiration under oxidative stress10.3390/ijms21041542 ↗
33. Selection of polymers for application in scaffolds applicable for human pancreatic islet transplantation10.1088/1748-6041/11/3/035006 ↗
34. DAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-110.1038/srep14623 ↗
35. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets10.1007/s001250050673 ↗
36. Factors influencing the mechanical stability of alginate beads applicable for immunoisolation of mammalian cells10.1016/j.jmbbm.2014.05.020 ↗
37. A novel multilayer immunoisolating encapsulation system overcoming protrusion of cells10.1038/srep06856 ↗
38. Factors influencing functional survival of microencapsulated islet grafts10.3727/000000004783983738 ↗
39. Extracellular matrix-associated factors play critical roles in regulating pancreatic β-cell proliferation and survival10.1210/en.2019-00206 ↗
40. I. Camaya, S. Donnelly, B. O’Brien, Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes, J. Diabetes n/a.
41. ERK signalling: a master regulator of cell behaviour, life and fate10.1038/s41580-020-0255-7 ↗
42. Cytokines in the progression of pancreatic β-cell dysfunction10.1155/2010/515136 ↗
43. Essential phospholipids prevent islet damage induced by proinflammatory cytokines and hypoxic conditions10.1002/dmrr.2714 ↗
44. Cytokine-induced translocation of GRP78 to the plasma membrane triggers a pro-apoptotic feedback loop in pancreatic beta cells10.1038/s41419-019-1518-0 ↗
45. Oxygen environment and islet size are the primary limiting factors of isolated pancreatic islet survival10.1371/journal.pone.0183780 ↗
46. MIN6 beta-cell-beta-cell interactions influence insulin secretory responses to nutrients and non-nutrients10.1016/j.bbrc.2006.02.003 ↗
47. Extracellular matrix-derived biomaterials in engineering cell function10.1016/j.biotechadv.2019.107421 ↗
48. Interpenetrating network of alginate–human adipose extracellular matrix hydrogel for islet cells encapsulation10.1002/marc.202000275 ↗
49. Effect of alginate matrix engineered to mimic the pancreatic microenvironment on encapsulated islet function10.1002/bit.27641 ↗
50. Regulation of human beta-cell adhesion, motility, and insulin secretion by collagen IV and its receptor alpha1beta110.1074/jbc.M411202200 ↗
51. What is the role of peptide fragments of collagen I and IV in health and disease?10.1016/j.lfs.2019.04.042 ↗
52. Necroptosis in health and diseases10.1016/j.semcdb.2014.07.013 ↗
53. Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure10.1016/j.fob.2014.08.007 ↗
54. Necrostatin-1 inhibits Hmgb1-IL-23/IL-17 pathway and attenuates cardiac ischemia reperfusion injury10.1111/tri.12349 ↗
55. NO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic β-cells10.1016/j.febslet.2011.08.028 ↗
56. Mitochondria as multifaceted regulators of cell death10.1038/s41580-019-0173-8 ↗
57. RIP3 targets pyruvate dehydrogenase complex to increase aerobic respiration in TNF-induced necroptosis10.1038/s41556-017-0022-y ↗
58. Anti-inflammatory strategies to enhance islet engraftment and survival10.1007/s11892-013-0401-0 ↗
59. Enhanced function of pancreatic islets co-encapsulated with ECM proteins and mesenchymal stromal cells in a silk hydrogel10.1016/j.biomaterials.2012.06.015 ↗
60. Mitochondrial signal transduction in pancreatic β-cells10.1016/j.beem.2012.07.003 ↗
61. Mitochondrial function and insulin secretion10.1016/j.mce.2013.06.019 ↗
62. The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus10.1089/ars.2016.6755 ↗
63. Mitochondrial dynamics and morphology in beta-cells10.1016/j.beem.2012.05.004 ↗
64. Mitochondrial networking protects beta-cells from nutrient-induced apoptosis10.2337/db07-1781 ↗
65. Drp1 guarding of the mitochondrial network is important for glucose-stimulated insulin secretion in pancreatic beta cells10.1016/j.bbrc.2016.04.142 ↗
66. Mitofusin 2 participates in mitophagy and mitochondrial fusion against angiotensin ii-induced cardiomyocyte injury10.3389/fphys.2019.00411 ↗
67. Inflammatory response in islet transplantation10.1155/2014/451035 ↗
68. Mitochondria: much ado about nothing? How dangerous is reactive oxygen species production?10.1016/j.biocel.2015.01.021 ↗
69. Low methyl-esterified pectin protects pancreatic β-cells against diabetes-induced oxidative and inflammatory stress via galectin-310.1016/j.carbpol.2020.116863 ↗
70. Extracellular matrix induction of intracellular reactive oxygen species10.1089/ars.2017.7305 ↗
71. Redox-relevant aspects of the extracellular matrix and its cellular contacts via integrins10.1089/ars.2013.5294 ↗
72. RIP1-dependent reactive oxygen species production executes artesunate-induced cell death in renal carcinoma Caki cells10.1007/s11010-017-3052-7 ↗